Abstract
Epithelial–mesenchymal transition (EMT) is a fundamental process that occurs during embryogenesis and tissue repair. However, EMT can be hijacked by malignant cells, where it may promote immune evasion and metastasis. Classically considered a dichotomous transition, EMT in cancer has recently been considered a plastic process whereby malignant cells display and interconvert among hybrid epithelial/mesenchymal (E/M) states. Epithelial–mesenchymal plasticity (EMP) and associated hybrid E/M states are divergent from classical EMT, with unique immunomodulatory effects. Here, we review recent insights into the EMP-immune crosstalk, highlighting possible mechanisms of immune evasion conferred by hybrid E/M states and roles of immune cells in EMP.
Cite
CITATION STYLE
Mullins, R. D. Z., Pal, A., Barrett, T. F., Heft Neal, M. E., & Puram, S. V. (2022, July 1). Epithelial–Mesenchymal Plasticity in Tumor Immune Evasion. Cancer Research. American Association for Cancer Research Inc. https://doi.org/10.1158/0008-5472.CAN-21-4370
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.